SAN DIEGO, California – nanoComposix has signed an agreement with BIOZOL Diagnostica Vertrieb GmbH (biozol.de/de) to broaden the distribution of nanoComposix products to customers throughout Germany and Austria. nanoComposix (nanocomposix.com) manufactures an array of nanomaterials to enable development of technologies ranging from lateral flow assay diagnostics and targeted drug delivery, to optical displays and lighting applications. The company offers hundreds of different variants of material, size, shape, and surface as standard products and has produced thousands of custom core/shell, biofunctionalized, fluorescent, and magnetic nanocomposites to meet client specifications. All materials are provided with certificates of analysis that include electron microscopy, hydrodynamic diameter, and optical measurements for each batch to guarantee products meet specifications. Contract manufacturing is performed on scales ranging from small beakers to thousands of liters. Nanomaterials for medical devices and clinical trials are produced in ISO13485 and cGMP compliant cleanroom facilities.
BIOZOL Diagnostica Vertrieb GmbH markets and distributes products for immunology, cell biology, molecular biology, biochemistry and human and veterinary diagnostics, such as antibodies, recombinant proteins, ELISA/EIA, detection kits, biochemicals and further reagents for cell culture, flow cytometry, immunohistology and cytogenetics.
nanoComposix can be visited online at: nanocomposix.com
BIOZOL Diagnostica Vertrieb GmbH can be visited online at: biozol.de/de